BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 18519085)

  • 1. Vasopressin receptor mutations in nephrogenic diabetes insipidus.
    Bichet DG
    Semin Nephrol; 2008 May; 28(3):245-51. PubMed ID: 18519085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrogenic diabetes insipidus.
    Bichet DG
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin receptor mutations causing nephrogenic diabetes insipidus.
    Bichet DG; Turner M; Morin D
    Proc Assoc Am Physicians; 1998; 110(5):387-94. PubMed ID: 9756088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG
    Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of mutations in the arginine vasopressin receptor 2 gene causing nephrogenic diabetes insipidus in Chinese patients.
    Chen CH; Chen WY; Liu HL; Liu TT; Tsou AP; Lin CY; Chao T; Qi Y; Hsiao KJ
    J Hum Genet; 2002; 47(2):66-73. PubMed ID: 11916004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus.
    Bernier V; Morello JP; Zarruk A; Debrand N; Salahpour A; Lonergan M; Arthus MF; Laperrière A; Brouard R; Bouvier M; Bichet DG
    J Am Soc Nephrol; 2006 Jan; 17(1):232-43. PubMed ID: 16319185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathological aspects of water transport in the collecting ducts].
    Bichet DG
    Nephrologie; 1996; 17(7):417-22. PubMed ID: 9019668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C112R, W323S, N317K mutations in the vasopressin V2 receptor gene in patients with nephrogenic diabetes insipidus. Mutations in brief no. 165. Online.
    Szalai C; Triga D; Czinner A
    Hum Mutat; 1998; 12(2):137-8. PubMed ID: 10694923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
    Bichet DG; Bockenhauer D
    Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
    Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
    Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular biological studies on patients with nephrogenic diabetes insipidus].
    Szalai C; Molnár E; Sallay P; Czinner A
    Orv Hetil; 1998 Apr; 139(15):883-7. PubMed ID: 9579101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide.
    Schoneberg T; Yun J; Wenkert D; Wess J
    EMBO J; 1996 Mar; 15(6):1283-91. PubMed ID: 8635461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nephrogenic diabetes insipidus].
    Bichet DG
    Nephrol Ther; 2006 Nov; 2(6):387-404. PubMed ID: 17081961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance.
    Spanakis E; Milord E; Gragnoli C
    J Cell Physiol; 2008 Dec; 217(3):605-17. PubMed ID: 18726898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrogenic diabetes insipidus.
    Morello JP; Bichet DG
    Annu Rev Physiol; 2001; 63():607-30. PubMed ID: 11181969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of nonpeptide (ant)agonists to rescue vasopressin V2 receptor mutants for the treatment of X-linked nephrogenic diabetes insipidus.
    Los EL; Deen PM; Robben JH
    J Neuroendocrinol; 2010 May; 22(5):393-9. PubMed ID: 20163515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Congenital nephrogenic diabetes insipidus].
    Thibonnier M
    Rev Prat; 1994 May; 44(9):1169-72. PubMed ID: 7939338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and cellular defects in nephrogenic diabetes insipidus.
    Knoers NV; Deen PM
    Pediatr Nephrol; 2001 Dec; 16(12):1146-52. PubMed ID: 11793119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.
    Tsukaguchi H; Matsubara H; Taketani S; Mori Y; Seido T; Inada M
    J Clin Invest; 1995 Oct; 96(4):2043-50. PubMed ID: 7560098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analyses of the vasopressin type 2 receptor and aquaporin-2 genes in Brazilian kindreds with nephrogenic diabetes insipidus.
    Rocha JL; Friedman E; Boson W; Moreira A; Figueiredo B; Liberman B; de Lacerda L; Sandrini R; Graf H; Martins S; Puñales MK; De Marco L
    Hum Mutat; 1999; 14(3):233-9. PubMed ID: 10477431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.